Triple-negative breast cancer (TNBC) is a breast cancer subtype lacking expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.